<;br />; The present invention relates to pharmaceutical dosage forms for oral administration comprising the drug substance 4-[(5R)-6, 7- dihydro-5H-pyrrolo[l,2-c]imidazol-5-yl]-3- fluorobenzonitrile or any pharmaceutically acceptable sait thereof and to processes of making said solid pharmaceutical dosage forms.